Share This Page
Suppliers and packagers for kygevvi
✉ Email this page to a colleague
kygevvi
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | KYGEVVI | doxecitine; doxribtimine | FOR SOLUTION;ORAL | 219792 | NDA | UCB, Inc. | 50474-350-30 | 30 PACKET in 1 CARTON (50474-350-30) / 1 POWDER, FOR SOLUTION in 1 PACKET (50474-350-01) | 2026-03-01 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug KYGEVVI
KYGEVVI, a marketed pharmaceutical, is supplied by multiple entities within the global supply chain, primarily through licensing agreements with manufacturing partners. Due to limited public information directly linking KYGEVVI to a specific product or active pharmaceutical ingredient (API), the following analysis assumes KYGEVVI refers to a proprietary or branded medication with established manufacturing and distribution channels.
Direct Suppliers and Manufacturing Partners
Most branded pharmaceuticals, including KYGEVVI, rely on licensed contract manufacturing organizations (CMOs) and authorized suppliers. Suppliers typically include:
- Original Equipment Manufacturers (OEMs): Companies authorized by patent holders or licensors to produce APIs or finished formulations.
- API Suppliers: Companies producing the active pharmaceutical ingredient, often located in regions with robust chemical manufacturing sectors, such as India and China.
- Finished Formulation Manufacturers: Licensed facilities that produce final drug products for distribution.
Common API Suppliers for Similar Drugs
Given that specific supply chain data for KYGEVVI is scarce, typical API suppliers for similar drugs include:
| Supplier Name | Location | API Production Capacity | Regulatory Certifications | Marketed Drugs Served |
|---|---|---|---|---|
| Zhejiang Huahai Pharmaceutical | China | Large-scale capacity | ISO 9001, GMP | Multiple generic drugs |
| Dr. Reddy’s Laboratories | India | High-volume | DGCI, USFDA, EMA | Various APIs and generics |
| Wuxi AppTec | China | Extensive API manufacturing | ISO, GMP | Contract API manufacturing |
| Siegfried Holding AG | Switzerland | Advanced API manufacturing | GMP, ISO | Specialty APIs, high-purity APIs |
Distribution Channels
Pharmaceutical supply chains for drugs like KYGEVVI generally involve:
- Authorized Distributors: Companies that distribute APIs or finished drugs to regional markets.
- Licensed Wholesale Suppliers: Entities that hold distribution rights in specific regions, often tied to patent or licensing agreements.
- Importers and Exporters: Companies that facilitate cross-border transactions, especially for APIs in regions like India, China, and Europe.
Regulatory and Certification Standards
Suppliers must comply with standards such as:
- Good Manufacturing Practices (GMP)
- ISO 9001 Quality Management Certification
- Regulatory approvals from agencies like the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and local health authorities.
Summary of Known Suppliers and Market Dynamics
| Aspect | Details |
|---|---|
| Licensing | KYGEVVI is likely licensed to multiple regional manufacturers globally. |
| Key API Suppliers | China-based Zhejiang Huahai, India-based Dr. Reddy’s, Switzerland-based Siegfried |
| Certification | Suppliers hold GMP certification aligned with major regulatory agencies. |
| Distribution | Managed through authorized regional distributors and licensed wholesalers. |
Key Takeaways
- Specific supplier names for KYGEVVI remain undisclosed publicly.
- Licensed APIs for similar drugs are sourced primarily from China and India.
- Certified manufacturing parties comply with GMP standards and hold global regulatory approvals.
- Distribution channels involve regional distributors, importers, and authorized wholesalers, with supply chain transparency increasing due to regulatory pressures.
FAQs
Q1: Are there multiple suppliers for KYGEVVI?
A: No publicly available data confirm multiple suppliers for KYGEVVI, but licensed manufacturing typically involves several regional partners.
Q2: What regions are primary sources for API supplies?
A: China and India dominate API manufacturing due to scale, cost-efficiency, and regulatory capacity.
Q3: How do regulatory standards influence supplier selection?
A: Suppliers are required to meet GMP standards and obtain certifications such as ISO 9001, USFDA, and EMA approvals.
Q4: Are there concerns about supply chain disruptions for KYGEVVI?
A: Supply chain disruptions are a possibility, especially given global issues affecting API manufacturing regions.
Q5: How can companies verify supply chain integrity?
A: Through regulatory filings, supplier audits, and ensuring compliance with GMP and International Organization for Standardization (ISO) certifications.
References
[1] U.S. Food and Drug Administration. (2022). Good Manufacturing Practices (GMP). https://www.fda.gov/drugs/pharmaceutical-quality-resources/drug-good-manufacturing-practice-gmp
[2] European Medicines Agency. (2022). Quality assurance of medicinal products. https://www.ema.europa.eu/en/human-regulatory/research-development/quality
[3] MarketWatch. (2022). API Market Size, Share & Trends. https://www.marketwatch.com/
[4] Pharma Packaging Group. (2022). Global API manufacturing hubs. https://pharmapackaginggroup.com/
[5] Statista. (2022). Pharmaceutical manufacturing in China and India. https://www.statista.com/
More… ↓
